More than 30 from MIT named to Forbes 30 Under 30 lists
Forbes calls its 2019 30 Under 30 honorees “a collection of bold risk-takers who are putting a new twist on the old tools of the trade.”
Forbes calls its 2019 30 Under 30 honorees “a collection of bold risk-takers who are putting a new twist on the old tools of the trade.”
MIT spinoff is changing the way mosquito-borne illnesses are diagnosed and aims to influence how public health officials react to disease outbreaks.
Model predicts whether ER patients suffering from sepsis urgently need a change in therapy.
Smartphone app developed by Emily Lindemer PhD '17 uses social contacts and location information to give gentle reminders for staying engaged with recovery.
PhD student Richard Fineman is using wearable sensors to understand coordination and walking — and next-generation spacesuit design.
MIT researchers develop new tools to enable targeted delivery of drugs to deep brain structures through implanted microprobes.
Researchers generate an intestinal cell mimic that can be harnessed in studies of diseases such as inflammatory bowel disease.
“Therepi” device attaches directly to damaged heart, enabling delivery of medicine from a port under a patient’s skin to augment cardiac function.
Award honors top collegiate inventors in the United States.
Longtime biology professor and expert in hemoglobin synthesis was committed to the integration of biomedical research, education, and medical practice.
A faculty member at MIT and Harvard and a practicing cardiologist, Edelman will lead MIT’s hub for health science research, innovation, and education.
Award honors immigrants’ contributions to the United States.
Synthetic biologist hopes to develop treatments for cancer and other diseases.
Microscopic flaws in material structure can lead to stent deformation after implantation.
Novel technology could allow researchers to develop and test new antimalaria drugs.